Cardio's blood sugar benefit plateaus at 100 minutes a week

Aerobic exercise is a cornerstone of type 2 diabetes management, and earlier pooled analyses had already shown it improves glycaemic control. What remained genuinely contested was dose: how much weekly exercise is needed for a meaningful drop in HbA1c, the standard marker of long-term blood glucose, and whether more always means better. That question matters practically, because the answer determines whether the substantial time cost of large exercise volumes buys proportionate metabolic benefit. This review set out to map the full dose-response curve rather than report a single average effect.

The authors searched PubMed, Scopus and Web of Science up to May 2021 for randomised trials of supervised aerobic training lasting 12 weeks or longer in adults with type 2 diabetes. Twenty-six trials with 1253 participants were analysed using a random-effects dose-response meta-analysis, which models how the effect changes across different weekly exercise durations. Secondary outcomes included changes in glucose-lowering medications, hypoglycaemic reactions, adverse events and quality of life, and evidence certainty was graded for each.

Each 30 minutes per week of supervised aerobic training reduced HbA1c by 0.22 percentage points, a finding graded as strong. The reduction grew proportionally with duration up to 100 minutes per week of moderate to vigorous training, where the drop reached 0.96 percentage points, and the curve flattened at higher durations. Exercise also reduced use of antidiabetic medications by 13 per 100 patients, but increased hypoglycaemic reactions by 10 per 100 and adverse events by 4 per 100, though these secondary findings carried lower certainty. Evidence on quality of life was limited.

This confirms the established view that aerobic exercise improves glycaemic control and adds the piece previous analyses lacked: the shape of the dose-response curve. The plateau at 100 minutes per week is the striking result, because it sits well below common assumptions about how much exercise a metabolic benefit requires. It is worth noting the plateau applies specifically to HbA1c; the review does not address whether higher volumes bring other benefits, such as fitness or weight outcomes, which remains an open question, as does the role of exercise intensity and type beyond supervised aerobic work.

For anyone managing or worried about type 2 diabetes, this is a reason to think small amounts of aerobic exercise count: measurable HbA1c benefit began at just 30 minutes a week, an amount almost anyone can find. It also reframes the ceiling, since the blood sugar benefit specifically topped out around 100 minutes weekly. The medication and hypoglycaemia findings are a reminder that exercise genuinely changes glucose handling, which is why people on glucose-lowering drugs typically coordinate training changes with their clinician.